shijiazhuang leveling import and export co.,ltd
Leveling technology Co., Ltd. is a modern company integrating research, production, sales and service. The company focuses on the development of PDO and hyaluronic acid specializes in the Beauty area and has been vigorously engaged in the development, production and marketing of Beauty machine, PDO Thread and hyaluronic acid. Has it's own independent Thread and. level filler hyaluronic acid and Level Thread With the faith of winning by quality and sincere service, provides the best service for all the customers. The company strictly operates on the highest regulatory standards in compliance with local and international directives. Product safety is secured by state of the art sterilization techniques and rigorous quality assurance. Now LevelingTechnology Co., Ltd. Already has a stable and mature global market network and a large number of loyal consumers. In future, the company will send higher quality products to consumers in a more convenient and efficient way In today's competitive industry, in the tide of holy dreams to focus the PDO, constantly pioneering spirit, natural health and beauty products, professional and authoritative scientific research center, advocates the concept of skin care, and become one of the few large PDO and hyaluronic acid company in China, has its place in the international market.
shijiazhuang leveling import and export co.,ltd
Leveling technology Co., Ltd. is a modern company integrating research, production, sales and service. The company focuses on the development of PDO and hyaluronic acid specializes in the Beauty area and has been vigorously engaged in the development, production and marketing of Beauty machine, PDO Thread and hyaluronic acid. Has it's own independent Thread and. level filler hyaluronic acid and Level Thread With the faith of winning by quality and sincere service, provides the best service for all the customers. The company strictly operates on the highest regulatory standards in compliance with local and international directives. Product safety is secured by state of the art sterilization techniques and rigorous quality assurance. Now LevelingTechnology Co., Ltd. Already has a stable and mature global market network and a large number of loyal consumers. In future, the company will send higher quality products to consumers in a more convenient and efficient way In today's competitive industry, in the tide of holy dreams to focus the PDO, constantly pioneering spirit, natural health and beauty products, professional and authoritative scientific research center, advocates the concept of skin care, and become one of the few large PDO and hyaluronic acid company in China, has its place in the international market.
Zimmer Biomet Holdings, Inc.
Zimmer Biomet specializes in orthopedic products, including bone-cutting instruments, designed for precision in joint replacement and trauma surgeries.
Zimmer Biomet Holdings, Inc.
Zimmer Biomet specializes in orthopedic products, including bone-cutting instruments, designed for precision in joint replacement and trauma surgeries.
Smith & Nephew is a global medical technology company providing innovative bone-cutting tools for orthopedic and trauma surgeries.
Smith & Nephew plc
Smith & Nephew is a global medical technology company providing innovative bone-cutting tools for orthopedic and trauma surgeries.
B. Braun offers a comprehensive range of surgical instruments, including bone-cutting tools, known for their precision and durability.
B. Braun Melsungen AG
B. Braun offers a comprehensive range of surgical instruments, including bone-cutting tools, known for their precision and durability.
A multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.
Johnson & Johnson
A multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.
Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, pharmacies, and laboratories.
Cardinal Health, Inc.
Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, pharmacies, and laboratories.
Medline is a leading healthcare company providing medical supplies and equipment, including high-quality commode chairs for patients and caregivers.
Medline Industries, Inc.
Medline is a leading healthcare company providing medical supplies and equipment, including high-quality commode chairs for patients and caregivers.
Becton, Dickinson and Company
BD is a global medical technology company focusing on improving medication management, infection prevention, and diagnostic solutions.
Becton, Dickinson and Company
BD is a global medical technology company focusing on improving medication management, infection prevention, and diagnostic solutions.
Edwards Lifesciences Corporation
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. They also offer vascular access devices including catheters.
Edwards Lifesciences Corporation
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. They also offer vascular access devices including catheters.
Cook Medical Trading (China) Co., Ltd.
Cook Medical is a medical device company from Indiana, USA. It was founded in 1963 by Mr. Bill Cook and his wife. Currently, Cook Medical's business covers 135 countries and regions around the world, with products covering more than 60 professional disciplines, and its production bases are mainly located in the United States, Europe and Australia. It has 6 major logistics distribution centers, multiple local warehousing and distribution centers, as well as more than 10,000 employees worldwide. Since its establishment, Cook Medical has adhered to the operating model of a family business. Unlike listed companies, unique individuality gives full space to consider issues from a long-term perspective, and there is no need to compromise on short-term business interests, truly adhering to the concept, original intention, and realizing the commitment to patients. The company's products have been in the Chinese market for more than 30 years. In 2008, Cook (China) Medical Trading Co., Ltd. was established in Shanghai. Currently, Cook China has two offices in Shanghai and Beijing, of which the Shanghai office is the operation headquarters of Cook China. In the future, Cook Medical will move forward steadily with full enthusiasm and confidence, professional knowledge and rich experience, and provide better products to serve patients and physicians.
Cook Medical Trading (China) Co., Ltd.
Cook Medical is a medical device company from Indiana, USA. It was founded in 1963 by Mr. Bill Cook and his wife. Currently, Cook Medical's business covers 135 countries and regions around the world, with products covering more than 60 professional disciplines, and its production bases are mainly located in the United States, Europe and Australia. It has 6 major logistics distribution centers, multiple local warehousing and distribution centers, as well as more than 10,000 employees worldwide. Since its establishment, Cook Medical has adhered to the operating model of a family business. Unlike listed companies, unique individuality gives full space to consider issues from a long-term perspective, and there is no need to compromise on short-term business interests, truly adhering to the concept, original intention, and realizing the commitment to patients. The company's products have been in the Chinese market for more than 30 years. In 2008, Cook (China) Medical Trading Co., Ltd. was established in Shanghai. Currently, Cook China has two offices in Shanghai and Beijing, of which the Shanghai office is the operation headquarters of Cook China. In the future, Cook Medical will move forward steadily with full enthusiasm and confidence, professional knowledge and rich experience, and provide better products to serve patients and physicians.
Teleflex Medical Device Trading (Shanghai) Co., Ltd.
Teleflex is a global provider of medical technology dedicated to improving people's health and quality of life. Using a goal-driven innovation approach, Teleflex continues to explore unmet clinical needs, providing support to healthcare professionals who are constantly working to create a healthy future. Teleflex’s portfolio offers solutions in vascular access and interventional therapy, surgery, anesthesia, cardiac care, urinary, acute medicine and respiratory care. More than 14,000 Teleflex employees around the world are united and united, believing that what they do every day is of great significance. Teleflex’s brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®.
Teleflex Medical Device Trading (Shanghai) Co., Ltd.
Teleflex is a global provider of medical technology dedicated to improving people's health and quality of life. Using a goal-driven innovation approach, Teleflex continues to explore unmet clinical needs, providing support to healthcare professionals who are constantly working to create a healthy future. Teleflex’s portfolio offers solutions in vascular access and interventional therapy, surgery, anesthesia, cardiac care, urinary, acute medicine and respiratory care. More than 14,000 Teleflex employees around the world are united and united, believing that what they do every day is of great significance. Teleflex’s brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®.
Intuitive Fosun Medical Device Technology (Shanghai) Co., Ltd.
In 2017, Fosun Pharma and US Insight Medical, a global leader in medical surgical robots, formed a joint venture in China Insight Fosun. Since its establishment, Fosun has always adhered to the core values of "patient first" and adhered to the purpose of "Made in China, joint research and development, and global sales". The company's star products, Da Vinci surgical system and Ion bronchoscopic operation control system (not available in China), have been widely recognized and used around the world as revolutionary products that guide the development of minimally invasive surgery. By empowering Chinese medical institutions and doctors, we will then allow cutting-edge minimally invasive surgical technology to benefit Chinese patients, and contribute to the innovation and development of China's medical industry with the determination of openness, inclusiveness, inclusiveness, balance and win-win. The company firmly believes that minimally invasive diagnosis and treatment technology is designed to improve the quality of life; it integrates originality and intelligent technology to provide unlimited possibilities for doctors and patients. Intuitive Fosun has always been concerned about the development trend of China's medical and health industry. With the purpose of "Made in China, joint research and development, global sales", it has deepened its roots in China and served China, and continuously introduced high-quality and effective innovative medical technologies and products to meet medical personnel and Patient needs. In July 2022, the medical robot manufacturing and R&D center of the intuitive Fosun headquarters and industrialization base project officially started construction. This is another major strategic layout after the completion of the Da Vinci Innovation Center in 2021. It marks the integration of multiple locations into a large park including production and manufacturing and innovation centers, and it is also the deepening of localization of Fosun. Another important milestone in the strategic layout.
Intuitive Fosun Medical Device Technology (Shanghai) Co., Ltd.
In 2017, Fosun Pharma and US Insight Medical, a global leader in medical surgical robots, formed a joint venture in China Insight Fosun. Since its establishment, Fosun has always adhered to the core values of "patient first" and adhered to the purpose of "Made in China, joint research and development, and global sales". The company's star products, Da Vinci surgical system and Ion bronchoscopic operation control system (not available in China), have been widely recognized and used around the world as revolutionary products that guide the development of minimally invasive surgery. By empowering Chinese medical institutions and doctors, we will then allow cutting-edge minimally invasive surgical technology to benefit Chinese patients, and contribute to the innovation and development of China's medical industry with the determination of openness, inclusiveness, inclusiveness, balance and win-win. The company firmly believes that minimally invasive diagnosis and treatment technology is designed to improve the quality of life; it integrates originality and intelligent technology to provide unlimited possibilities for doctors and patients. Intuitive Fosun has always been concerned about the development trend of China's medical and health industry. With the purpose of "Made in China, joint research and development, global sales", it has deepened its roots in China and served China, and continuously introduced high-quality and effective innovative medical technologies and products to meet medical personnel and Patient needs. In July 2022, the medical robot manufacturing and R&D center of the intuitive Fosun headquarters and industrialization base project officially started construction. This is another major strategic layout after the completion of the Da Vinci Innovation Center in 2021. It marks the integration of multiple locations into a large park including production and manufacturing and innovation centers, and it is also the deepening of localization of Fosun. Another important milestone in the strategic layout.
Stryker (Beijing) Medical Devices Co., Ltd.
As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.
Stryker (Beijing) Medical Devices Co., Ltd.
As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.
GE Healthcare is an innovator of global cutting-edge medical technology, diagnostic drugs and digital solutions. It is committed to making hospital operations more efficient, clinical diagnosis more effective, treatments more accurate, and patients healthier by providing integrated solutions, services, and data analysis. and happiness. In the more than 100 years of serving patients and medical institutions, GE Medical has continued to promote personalized, interconnected and more empathetic medical care, while simplifying the patient diagnosis and treatment process. GE Medical's medical imaging, ultrasound, life care and diagnostic drug business covers medical care in all aspects from diagnosis, treatment to monitoring. GE Medical was listed on the Nasdaq Stock Exchange in January 2023. The company's business covers more than 160 countries and regions. Since starting to serve Chinese patients in 1897, GE Medical has begun a century-long process of development in China. GE Medical established its China office in Beijing in 1986. In 1991, it jointly built a local factory "GE Hangwei" (Hangwei General Electric Medical Systems Co., Ltd.) with the former Ministry of Aerospace and the Ministry of Health. So far, it has been all over the country. It has more than 30 offices and has built three "creation centers" in Beijing, Wuxi and Shanghai. It has more than 7,000 employees and a local R&D team of about 1,800 people. Since 2011, it has led the research and development and marketed nearly 110 innovative products. In China, GE Medical has improved the accessibility of precision medicine and high-quality medical resources, and helped the construction of "Healthy China 2030". As one of the first multinational companies to start domestic layout, GE Medical has five major production bases (including six factories) in Beijing, Shanghai, Wuxi, Tianjin and Chengdu, and has built a "domestic" full coverage from universal and affordable to high-end. ability. GE Medical produces CT, X-ray machines, vascular machines, surgical machines and other imaging equipment in Beijing; builds a contrast agent production base in Shanghai; produces magnetic resonance imaging systems in Tianjin; produces ultrasound, anesthesia, electrocardiogram monitoring, and ventilators in Wuxi. , patient monitoring and other clinical nursing equipment. GE Medical's fifth production base in China is under construction in Chengdu; the production base of Sinopharm Devices and GE Medical Joint Venture is under construction in Shenzhen.
General Electric Company
GE Healthcare is an innovator of global cutting-edge medical technology, diagnostic drugs and digital solutions. It is committed to making hospital operations more efficient, clinical diagnosis more effective, treatments more accurate, and patients healthier by providing integrated solutions, services, and data analysis. and happiness. In the more than 100 years of serving patients and medical institutions, GE Medical has continued to promote personalized, interconnected and more empathetic medical care, while simplifying the patient diagnosis and treatment process. GE Medical's medical imaging, ultrasound, life care and diagnostic drug business covers medical care in all aspects from diagnosis, treatment to monitoring. GE Medical was listed on the Nasdaq Stock Exchange in January 2023. The company's business covers more than 160 countries and regions. Since starting to serve Chinese patients in 1897, GE Medical has begun a century-long process of development in China. GE Medical established its China office in Beijing in 1986. In 1991, it jointly built a local factory "GE Hangwei" (Hangwei General Electric Medical Systems Co., Ltd.) with the former Ministry of Aerospace and the Ministry of Health. So far, it has been all over the country. It has more than 30 offices and has built three "creation centers" in Beijing, Wuxi and Shanghai. It has more than 7,000 employees and a local R&D team of about 1,800 people. Since 2011, it has led the research and development and marketed nearly 110 innovative products. In China, GE Medical has improved the accessibility of precision medicine and high-quality medical resources, and helped the construction of "Healthy China 2030". As one of the first multinational companies to start domestic layout, GE Medical has five major production bases (including six factories) in Beijing, Shanghai, Wuxi, Tianjin and Chengdu, and has built a "domestic" full coverage from universal and affordable to high-end. ability. GE Medical produces CT, X-ray machines, vascular machines, surgical machines and other imaging equipment in Beijing; builds a contrast agent production base in Shanghai; produces magnetic resonance imaging systems in Tianjin; produces ultrasound, anesthesia, electrocardiogram monitoring, and ventilators in Wuxi. , patient monitoring and other clinical nursing equipment. GE Medical's fifth production base in China is under construction in Chengdu; the production base of Sinopharm Devices and GE Medical Joint Venture is under construction in Shenzhen.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Abbott Trading (Shanghai) Co., Ltd.
In 1888, Abbott Pharmaceutical Factory was founded in Chicago, USA by its founder, Dr. Wallace C. Abbott, to help people in more than 160 countries and regions around the world live a wonderful life. Abbott has been operating in China as early as the 1930s and has been operating since 1988. Abbott is rooted in China and continues to expand its market. In the past 30 years, it has provided Chinese consumers with a variety of nutritional products, medicines and medical products. At present, in addition to establishing a Chinese headquarters in Shanghai, Abbott has also established 16 offices, 4 factories and 2 R&D centers, with more than 6,000 employees. Abbott develops, produces and distributes products covering nutritional products, medicines, medical devices and diagnostic products. Products and services meet the needs of many aspects from disease prevention to diagnosis, treatment to recovery, and are based on local needs to achieve common health goals. Since 2010, Abbott has continued to invest in the Chinese market, developing, producing and distributing products in China, covering nutritional products, medicines, medical devices and diagnostic products, products and services that can meet the needs of disease prevention to diagnosis and treatment to recovery. . In 2014, the advanced nutritional products factory established in Jiaxing with an investment of US$230 million was officially opened. This is a major investment project in China, showing Abbott's strong attempt to improve the health of all Chinese people. Abbott attaches importance to China's local R&D capabilities, not only establishes R&D centers in Shanghai, but also establishes Shanghai Children's Medical Center with partners. Through local clinical trials and operations, Abbott China's R&D capabilities have been greatly improved. In terms of medical innovation, Abbott China has worked together with other R&D centers around the world to jointly respond to global medical problems. Abbott believes in the potential of life and continues to launch high-quality products and services, ranging from newborns to adults, from nutrition and diagnostics to health care and medical treatment. Abbott's passion and care make science an inexhaustible spring for a healthy life, committed to stimulating everyone's potential and pursuing a healthier and better life.
Abbott Trading (Shanghai) Co., Ltd.
In 1888, Abbott Pharmaceutical Factory was founded in Chicago, USA by its founder, Dr. Wallace C. Abbott, to help people in more than 160 countries and regions around the world live a wonderful life. Abbott has been operating in China as early as the 1930s and has been operating since 1988. Abbott is rooted in China and continues to expand its market. In the past 30 years, it has provided Chinese consumers with a variety of nutritional products, medicines and medical products. At present, in addition to establishing a Chinese headquarters in Shanghai, Abbott has also established 16 offices, 4 factories and 2 R&D centers, with more than 6,000 employees. Abbott develops, produces and distributes products covering nutritional products, medicines, medical devices and diagnostic products. Products and services meet the needs of many aspects from disease prevention to diagnosis, treatment to recovery, and are based on local needs to achieve common health goals. Since 2010, Abbott has continued to invest in the Chinese market, developing, producing and distributing products in China, covering nutritional products, medicines, medical devices and diagnostic products, products and services that can meet the needs of disease prevention to diagnosis and treatment to recovery. . In 2014, the advanced nutritional products factory established in Jiaxing with an investment of US$230 million was officially opened. This is a major investment project in China, showing Abbott's strong attempt to improve the health of all Chinese people. Abbott attaches importance to China's local R&D capabilities, not only establishes R&D centers in Shanghai, but also establishes Shanghai Children's Medical Center with partners. Through local clinical trials and operations, Abbott China's R&D capabilities have been greatly improved. In terms of medical innovation, Abbott China has worked together with other R&D centers around the world to jointly respond to global medical problems. Abbott believes in the potential of life and continues to launch high-quality products and services, ranging from newborns to adults, from nutrition and diagnostics to health care and medical treatment. Abbott's passion and care make science an inexhaustible spring for a healthy life, committed to stimulating everyone's potential and pursuing a healthier and better life.
Siemens Medical is a world-renowned medical technology company. For 130 years, it has led the innovation of medical technology. The company continues to develop innovative products and services, including artificial intelligence-based applications and digital products that play an increasingly important role in the development of the new generation of medical technology, and further consolidates the fields of in vitro diagnosis, image-guided treatment, in vivo diagnosis and new cancer diagnosis and treatment. The basis of At the same time, Siemens Medical provides a wide range of services and solutions to help medical service providers improve their capabilities and provide patients with high-quality and efficient services. In order to achieve the goal of "Siemens Medical 2025 Strategy", by accelerating business expansion, exploring growth markets related to core businesses such as artificial intelligence, future diagnosis and treatment or technical support services, and completing the next phase of the goal in a more targeted way and method. , further consolidate our market leadership position. In China, Siemens Medical is committed to becoming a trusted partner for China's medical and health system and Chinese patients by meeting the most pressing medical needs. The company has launched a new China strategy for the next three years, and will be "customer-centric" in all aspects, targeting the differentiated needs of different customer groups, establishing a more focused and professional team, and providing an overall solution driven by digitalization. , meet the needs of Chinese customers. In 2022, Siemens Medical China officially released the localization strategy of "National Intelligence Innovation", aiming to deeply participate in the construction of a healthy China as a Chinese company. The upgraded strategy is divided into three dimensions: First, the company will gradually promote the localization of the entire product line, further enrich and improve the product lineage, meet the diversified needs of Chinese customers and patients, and help the local industrial chain transform and upgrade. Second, based on the demand of the Chinese market, the company further deepens its innovation and research and development. On the one hand, it accelerates the implementation of global leading technologies in China, benefiting doctors and patients as soon as possible, and on the other hand, it continues to explore local innovation. Third, the company continues to promote the upgrading of local business models, improve the large-scale application of medical equipment in all fields of the disease process, gradually improve the industrial ecology, and explore and practice multi-dimensional medical and industrial collaborative innovation model.
Siemens Healthineers AG
Siemens Medical is a world-renowned medical technology company. For 130 years, it has led the innovation of medical technology. The company continues to develop innovative products and services, including artificial intelligence-based applications and digital products that play an increasingly important role in the development of the new generation of medical technology, and further consolidates the fields of in vitro diagnosis, image-guided treatment, in vivo diagnosis and new cancer diagnosis and treatment. The basis of At the same time, Siemens Medical provides a wide range of services and solutions to help medical service providers improve their capabilities and provide patients with high-quality and efficient services. In order to achieve the goal of "Siemens Medical 2025 Strategy", by accelerating business expansion, exploring growth markets related to core businesses such as artificial intelligence, future diagnosis and treatment or technical support services, and completing the next phase of the goal in a more targeted way and method. , further consolidate our market leadership position. In China, Siemens Medical is committed to becoming a trusted partner for China's medical and health system and Chinese patients by meeting the most pressing medical needs. The company has launched a new China strategy for the next three years, and will be "customer-centric" in all aspects, targeting the differentiated needs of different customer groups, establishing a more focused and professional team, and providing an overall solution driven by digitalization. , meet the needs of Chinese customers. In 2022, Siemens Medical China officially released the localization strategy of "National Intelligence Innovation", aiming to deeply participate in the construction of a healthy China as a Chinese company. The upgraded strategy is divided into three dimensions: First, the company will gradually promote the localization of the entire product line, further enrich and improve the product lineage, meet the diversified needs of Chinese customers and patients, and help the local industrial chain transform and upgrade. Second, based on the demand of the Chinese market, the company further deepens its innovation and research and development. On the one hand, it accelerates the implementation of global leading technologies in China, benefiting doctors and patients as soon as possible, and on the other hand, it continues to explore local innovation. Third, the company continues to promote the upgrading of local business models, improve the large-scale application of medical equipment in all fields of the disease process, gradually improve the industrial ecology, and explore and practice multi-dimensional medical and industrial collaborative innovation model.
Mitutoyo Optical Technology (Shanghai) Co., Ltd.
The Olympus brand was founded in 1919, and in 1921, it independently developed the optical microscope "Xu". For ninety years, Olympus has always been at the forefront of this industry with its core competitiveness of "optical-digital technology", providing precision and professional microscope products to the field of life sciences. With the rapid development of technology, today's microscopes have long bid farewell to the simple optical structure of lenses. The application of microscopes is not limited to observing ordinary chromosomal specimens. With the breakthrough and innovation of Olympus optical technology, various things are more intelligent and more Advanced microscopes have been developed and used to provide reliable support for further exploring the mysteries of life: Olympus FSX100 takes "excellent image", "super simple operation" and "good ergonomic engineering" as its core concepts, and transforms the complexity. In order to simplify, everyone can easily obtain stable and accurate microscope images; the fully built-in laser scanning confocal microscope FV10i obtains a compact structure and a highly stable system through a fully built-in integrated design, making it even more powerful. The complex operation and maintenance of laser confocal microscopes have become history, reflecting the humanized design concept; FV1000-MPE, which has multi-photon laser scanning technology, can deeply observe thick specimens or internal cores of body specimens, and for neuroscience and The research on tissue engineering of artificial organs has had an extremely profound impact, opening a new era of in-depth observation of microscopes. Olympus microscope products have always represented the advanced level of the industry, and are widely used in life sciences and industrial research, and have been well received by users and scientific research institutions. In April 2023, Bain Capital announced that the private equity firm has acquired Evident, former scientific solutions division of Olympus, after obtaining regulatory approval in Japan and other jurisdictions. The Science Division of the Olympus Industrial and Life Sciences business is responsible for Olympus.
Mitutoyo Optical Technology (Shanghai) Co., Ltd.
The Olympus brand was founded in 1919, and in 1921, it independently developed the optical microscope "Xu". For ninety years, Olympus has always been at the forefront of this industry with its core competitiveness of "optical-digital technology", providing precision and professional microscope products to the field of life sciences. With the rapid development of technology, today's microscopes have long bid farewell to the simple optical structure of lenses. The application of microscopes is not limited to observing ordinary chromosomal specimens. With the breakthrough and innovation of Olympus optical technology, various things are more intelligent and more Advanced microscopes have been developed and used to provide reliable support for further exploring the mysteries of life: Olympus FSX100 takes "excellent image", "super simple operation" and "good ergonomic engineering" as its core concepts, and transforms the complexity. In order to simplify, everyone can easily obtain stable and accurate microscope images; the fully built-in laser scanning confocal microscope FV10i obtains a compact structure and a highly stable system through a fully built-in integrated design, making it even more powerful. The complex operation and maintenance of laser confocal microscopes have become history, reflecting the humanized design concept; FV1000-MPE, which has multi-photon laser scanning technology, can deeply observe thick specimens or internal cores of body specimens, and for neuroscience and The research on tissue engineering of artificial organs has had an extremely profound impact, opening a new era of in-depth observation of microscopes. Olympus microscope products have always represented the advanced level of the industry, and are widely used in life sciences and industrial research, and have been well received by users and scientific research institutions. In April 2023, Bain Capital announced that the private equity firm has acquired Evident, former scientific solutions division of Olympus, after obtaining regulatory approval in Japan and other jurisdictions. The Science Division of the Olympus Industrial and Life Sciences business is responsible for Olympus.
Pocos International Medical Trading (Shanghai) Co., Ltd.
Boston Science continues to develop breakthrough medical technologies and products, contributing to the progress of multiple medical fields. Committed to reducing patient trauma, reducing medical costs, and effectively improving the quality of life. Boston Science currently owns more than 13,000 life-improving products, and the company invests more than $1 billion in research and development every year. Boston Science is committed to improving people's lives and improving the health quality of patients around the world through innovative medical solutions. Innovating for life is the mission of Boston Science and a commitment to patients, physicians and medical systems around the world. About 30 million patients benefit from Boston’s scientific innovative medical solutions each year.
Pocos International Medical Trading (Shanghai) Co., Ltd.
Boston Science continues to develop breakthrough medical technologies and products, contributing to the progress of multiple medical fields. Committed to reducing patient trauma, reducing medical costs, and effectively improving the quality of life. Boston Science currently owns more than 13,000 life-improving products, and the company invests more than $1 billion in research and development every year. Boston Science is committed to improving people's lives and improving the health quality of patients around the world through innovative medical solutions. Innovating for life is the mission of Boston Science and a commitment to patients, physicians and medical systems around the world. About 30 million patients benefit from Boston’s scientific innovative medical solutions each year.
3M Company was founded in 1902 and is headquartered in St. Paul, Minnesota, USA. As a world-renowned diversified technology innovation enterprise, 3M's products and technologies have long been deeply integrated into people's lives. Over the past 100 years, 3M has developed more than 60,000 products, from household supplies to medical products, from transportation, construction to commerce, education and electronics, communications and other fields. 3M China Co., Ltd. was registered and established in Shanghai in November 1984. It is a wholly foreign-owned enterprise established outside the Shenzhen Special Economic Zone. Up to now, 3M has established 7 production bases, 4 technology centers and 1 R&D center in China, providing more than 6,000 jobs. As a recognized enterprise pioneer in the field of R&D, 3M has R&D capabilities in 50 countries around the world. 3M China R&D Center was established in 1994. It is one of 3M's four largest R&D centers in the world. It has more than 40 international first-class laboratories and more than 600 scientific researchers. In addition, 3M also has 4 technical centers in China. The core technology full of infinite possibilities is the source of innovation for 3M's diversification and more than 50,000 products. With 49 core technology platforms, scientific researchers from different industries and fields conduct exchanges and research in diversified technical fields here, providing customers with multi-faceted technical support from technical services to new product development, solutions to process design, and Assist in establishing relevant technical specifications. In order to enable customers and all sectors of society to better understand 3M's technological innovation, the company has established 3M customer innovation centers in 3M China R&D Center (Shanghai) and various technology centers. 3M Customer Innovation Center is known as the "cradle of innovation" of 3M. It focuses on displaying 3M's core technology and diversified market applications, leading every guest into the 3M's charming innovation world through novel and interesting interactive experience. With the four major market-oriented business departments, 3M transforms creativity into thousands of innovative products and solutions, creating value for customers and improving people's daily life quality.
3M China Limited
3M Company was founded in 1902 and is headquartered in St. Paul, Minnesota, USA. As a world-renowned diversified technology innovation enterprise, 3M's products and technologies have long been deeply integrated into people's lives. Over the past 100 years, 3M has developed more than 60,000 products, from household supplies to medical products, from transportation, construction to commerce, education and electronics, communications and other fields. 3M China Co., Ltd. was registered and established in Shanghai in November 1984. It is a wholly foreign-owned enterprise established outside the Shenzhen Special Economic Zone. Up to now, 3M has established 7 production bases, 4 technology centers and 1 R&D center in China, providing more than 6,000 jobs. As a recognized enterprise pioneer in the field of R&D, 3M has R&D capabilities in 50 countries around the world. 3M China R&D Center was established in 1994. It is one of 3M's four largest R&D centers in the world. It has more than 40 international first-class laboratories and more than 600 scientific researchers. In addition, 3M also has 4 technical centers in China. The core technology full of infinite possibilities is the source of innovation for 3M's diversification and more than 50,000 products. With 49 core technology platforms, scientific researchers from different industries and fields conduct exchanges and research in diversified technical fields here, providing customers with multi-faceted technical support from technical services to new product development, solutions to process design, and Assist in establishing relevant technical specifications. In order to enable customers and all sectors of society to better understand 3M's technological innovation, the company has established 3M customer innovation centers in 3M China R&D Center (Shanghai) and various technology centers. 3M Customer Innovation Center is known as the "cradle of innovation" of 3M. It focuses on displaying 3M's core technology and diversified market applications, leading every guest into the 3M's charming innovation world through novel and interesting interactive experience. With the four major market-oriented business departments, 3M transforms creativity into thousands of innovative products and solutions, creating value for customers and improving people's daily life quality.
